Relmada Therapeutics, Inc.
RLMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001553643
In the last 90 days, Relmada Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $693.7M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Relmada Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −4 vs. Q4 2024
- Shares held
- 6.22M
- −2.18M (−26.0%) vs. Q4 2024
- Total value
- $1.68M
- −$2.68M (−61.5%) vs. Q4 2024
- New holders
- 8
- 4 more added
- Sold out
- 12
- 14 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RLMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $693.7M |
| Q1 2026 | 103 | $588.8M |
| Q4 2025 | 78 | $245.8M |
| Q3 2025 | 44 | $15.5M |
| Q2 2025 | 50 | $3.18M |
| Q1 2025 | 44 | $1.68M |
| Q4 2024 | 48 | $4.36M |
| Q3 2024 | 69 | $40.2M |
| Q2 2024 | 79 | $40.7M |
| Q1 2024 | 93 | $66.5M |
| Q4 2023 | 83 | $56.4M |
| Q3 2023 | 88 | $45.0M |
| Q2 2023 | 95 | $39.7M |
| Q1 2023 | 91 | $40.3M |
| Q4 2022 | 110 | $66.8M |
| Q3 2022 | 134 | $953.6M |
| Q2 2022 | 113 | $468.5M |
| Q1 2022 | 113 | $623.1M |
| Q4 2021 | 97 | $467.2M |
| Q3 2021 | 87 | $262.8M |
| Q2 2021 | 85 | $318.3M |
| Q1 2021 | 82 | $335.7M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Relmada Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 2 | $1 | 0.00% | −62,947−100.0% | Reduced |
| Advisor Group Holdings, Inc. | 5 | $1 | 0.00% | −27−84.4% | Reduced |
| Front Row Advisors LLC | 6 | $2 | 0.00% | +6 | New |
| BNP Paribas Arbitrage, SA | 72 | $19 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 102 | $28 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 158 | $43 | 0.00% | −37,542−99.6% | Reduced |
| Morgan Stanley | 2,168 | $585 | 0.00% | −15,029−87.4% | Reduced |
| Simplex Trading, LLC | 4,482 | $1.00K | 0.00% | +4,482 | New |
| American Capital Advisory, LLC | 3,908 | $1.06K | 0.00% | +1,954+100.0% | Added |
| Hexagon Capital Partners LLC | 4,000 | $1.08K | 0.00% | 00.0% | Unchanged |
| Bedel Financial Consulting, Inc. | 10,000 | $3.57K | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 13,234 | $3.57K | 0.00% | +13,234 | New |
| Bank of America Corp | 13,716 | $3.70K | 0.00% | −192,941−93.4% | Reduced |
| Lido Advisors, LLC | 13,905 | $3.75K | 0.00% | +13,905 | New |
| Two Sigma Securities, LLC | 14,012 | $3.78K | 0.00% | +14,012 | New |
| Pandora Wealth, Inc. | 20,000 | $5.40K | 0.00% | +20,000 | New |
| Pensionmark Financial Group, LLC | 21,644 | $5.84K | 0.00% | −8,040−27.1% | Reduced |
| Tortoise Investment Management, LLC | 21,676 | $5.85K | 0.00% | 00.0% | Unchanged |
| Robertson Stephens Wealth Management, LLC | 25,000 | $6.75K | 0.00% | 00.0% | Unchanged |
| Wealthedge Investment Advisors, LLC | 28,000 | $7.56K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 28,641 | $7.73K | 0.00% | −73,446−71.9% | Reduced |
| AlTi Global, Inc. | 31,975 | $8.63K | 0.00% | 00.0% | Unchanged |
| SEI Investments Co | 36,230 | $9.78K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 40,270 | $10.9K | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 42,797 | $11.6K | 0.00% | −1,259,354−96.7% | Reduced |
| apricus wealth, LLC | 48,962 | $13.2K | 0.01% | 00.0% | Unchanged |
| HRT Financial LP | 52,043 | $14.0K | 0.00% | +52,043 | New |
| Northern Trust Corp | 59,571 | $16.1K | 0.00% | −24,711−29.3% | Reduced |
| We Are One Seven, LLC | 100,000 | $27.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 106,735 | $28.8K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 120,852 | $32.6K | 0.00% | +120,852 | New |
| Renaissance Technologies LLC | 124,100 | $33.5K | 0.00% | −40,413−24.6% | Reduced |
| UBS Group AG | 144,789 | $39.1K | 0.00% | −70,351−32.7% | Reduced |
| RBF Capital, LLC | 163,261 | $44.1K | 0.00% | 00.0% | Unchanged |
| Parsons Capital Management Inc | 163,336 | $44.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 170,544 | $46.0K | 0.00% | +42,965+33.7% | Added |
| Deutsche Bank AG | 224,846 | $60.7K | 0.00% | 00.0% | Unchanged |
| AdvisorShares Investments LLC | 276,514 | $75.7K | 0.01% | +66,446+31.6% | Added |
| Two Sigma Advisers, LP | 288,000 | $77.8K | 0.00% | +89,100+44.8% | Added |
| Geode Capital Management, LLC | 301,883 | $81.5K | 0.00% | −955−0.3% | Reduced |
| Palo Alto Investors LP | 495,146 | $133.7K | 0.03% | 00.0% | Unchanged |
| BlackRock, Inc. | 566,905 | $153.1K | 0.00% | −26,421−4.5% | Reduced |
| Vanguard Group Inc | 1,208,075 | $326.2K | 0.00% | −48,630−3.9% | Reduced |
| Acadian Asset Management LLC | 1,227,928 | $329.0K | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −200,825−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −145,999−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −124,773−100.0% | Sold out |
| Rosalind Advisors, Inc. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −72,600−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −45,602−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −30,062−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −14,428−100.0% | Sold out |
| Beaumont Capital Management, LLC | 0 | $0 | 0.00% | −11,006−100.0% | Sold out |
| Sargent Investment Group, LLC | 0 | $0 | 0.00% | −11,670−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −760−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −200−100.0% | Sold out |